mRNA research could be key to type 1 diabetes treatment
A team led by SVI’s Associate Professor Mark Chong, has been awarded a two-year grant from the Victorian Government’s new mRNA Research Acceleration Fund to push forward development of an Australian-first mRNA-based treatment for type 1 diabetes.
Testing the quality of a COVID RAT
Rapid antigen testing (RAT) for COVID-19 has quickly become a regular routine for many Australians, as a tool to support our return to schools, workplaces and ‘normal’ life.
Funding supports new approach to Alzheimer’s disease
A team led by SVI’s Professor Michael Parker was recently awarded a Faye Williams Innovation Grant from the Dementia Australia Research Foundation, to support testing of a potential new approach to treating Alzheimer’s disease.
ACMD forges ahead
Set to open in 2024, the $206 million ACMD facility will foster collaboration and enhance Victoria’s bioengineering research capabilities.
Using data to get personal with medicine
Machine learning has in recent years been gaining prominence across a number of domains, and this technology also has strong potential for application in bioinformatics and healthcare. A sub-field of artificial intelligence, machine learning involves ‘teaching’ a computer program to learn from its experience of data, resulting in better recognition of patterns over time.
Steps that lessen the pain
New SVI research on lipoedema – a debilitating chronic disease often misdiagnosed as obesity – provides a path to potential drug treatments and development of a diagnostic screening test.
Help us make discoveries that will transform lives
Type 1 diabetes is just one of many diseases that turn Australian lives upside down every day. Scientists at SVI are applying ‘big data’ analysis and artificial intelligence to drive quantum leaps in our knowledge of disease, including type 1 diabetes.
New funding brings medical discovery to life
SVI is excited to have secured a $2.5 million grant through The Ian Potter Foundation to support the Aikenhead Centre for Medical Discovery (ACMD). SVI is one of nine partners in the ACMD, a new centre that will accelerate bio-engineering medical solutions for people living with disease, and position Australia as a leader within a rapidly evolving global industry.
Revisiting the sequenator
Help us help people like Phil
Around 250 Australians are diagnosed with dementia every day, with the majority of these people affected by Alzheimer’s disease.
SVI scientists awarded NHMRC Ideas Grants
Congratulations to Dr Jacki Heraud-Farlow and Dr Kim Loh, who were both awarded Ideas Grants in the Australian Government’s National Health and Medical Research Council 2022 funding round.
Appointment of new auditors
SVI wishes to announce that the Auditors appointed to Audit the Financial Statutory Accounts for SVI have been changed, effective December 2022.